A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study-Reference-Cited by-同舟云学术

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Published:1999-11 Issue:2 Volume:75 Page:187-193
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lhommé C.,Vennin P.,Callet N.,Lesimple T.,Achard J.L.,Chauvergne J.,Luporsi E.,Chinet-Charrot P.,Coudert B.,Couette J.E.,Guastalla J.P.,Lebrun D.,Ispas S.,Blumberg J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Evolution de la Mortalité par Cancer en France 1950–1990. Mise à Jour 1986–1990;Hill,1993

2. Doxorubicin, cisplatin, vinblastine combination therapy of advanced endometrial carcinoma: a Southwest Oncology Group study;Alberts;Gynecol Oncol,1987

3. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma;Piver;Obstet Gynecol,1986

4. Corpus: Epithelial Tumors;Barakat,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of systemic therapy for disseminated endometrial cancer: literature review;Malignant tumours;2023-06-21

2. The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer;Cells;2021-02-01

3. Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options;American Society of Clinical Oncology Educational Book;2020-05

4. Management Strategies for Recurrent Endometrial Cancer;Expert Review of Anticancer Therapy;2018-07-04

5. Traitement médical du cancer de l’endomètre avancé;Bulletin du Cancer;2017-12